Tuberculosis screening in healthcare facilities follows specific, risk-tiered requirements for both healthcare workers and certain patient populations, reflecting TB's airborne transmission mechanism and the serious consequences of an undetected active case circulating within a facility before appropriate isolation begins.
Baseline and Ongoing Healthcare Worker Screening Follows a Risk-Tiered Approach
Current guidelines call for baseline TB testing at hire for all healthcare workers, with ongoing screening frequency determined by a facility's individual risk assessment rather than a uniform annual requirement applied regardless of actual exposure risk — a facility in a lower-TB-prevalence area with strong baseline infection control practices may have different ongoing screening frequency requirements than one in a higher-risk setting, reflecting a genuinely risk-based rather than one-size-fits-all approach to ongoing surveillance.
Interferon-Gamma Release Assays Have Largely Replaced the Traditional Skin Test
Blood-based interferon-gamma release assays (IGRA) have become the preferred TB screening method in many settings, offering advantages over the traditional tuberculin skin test including single-visit testing (no requirement to return within a specific window for result reading) and reduced false-positive results in individuals previously vaccinated with BCG, a vaccine used in many countries outside the U.S. that can cause false-positive skin test results without indicating actual TB infection.
Distinguishing Latent Infection From Active Disease Determines the Entire Response
A positive TB screening result requires follow-up evaluation, including chest imaging and clinical assessment, to distinguish latent TB infection — where the bacteria are present but inactive and the person is not infectious — from active TB disease, which requires immediate airborne isolation and represents a genuine transmission risk to others. This distinction fundamentally changes the appropriate response, and screening protocols must ensure this follow-up evaluation actually happens promptly rather than treating a positive screening result alone as the endpoint of the assessment process.
Patient Screening Applies in Specific High-Risk Encounter Contexts
Beyond healthcare worker screening, certain patient populations and clinical contexts warrant specific TB screening consideration — patients presenting with symptoms consistent with active TB, certain immunocompromised patients before starting specific immunosuppressive therapies, and patients from higher-prevalence regions in some clinical contexts. Recognizing when patient-level TB screening is clinically indicated, rather than assuming TB screening is purely an occupational health program for staff, is part of comprehensive facility TB prevention.
Airborne Isolation Infrastructure Must Actually Be Available When Needed
A facility's TB screening program is only as effective as its capacity to actually isolate a suspected or confirmed active case promptly — adequate negative pressure isolation room availability, and clear protocols for rapid isolation while diagnostic workup proceeds, close the loop between screening identification and the actual infection control response the screening program exists to enable.
Conclusion
Effective TB screening in healthcare facilities depends on risk-tiered testing frequency, modern testing methodology, prompt distinction between latent and active disease, and genuine isolation infrastructure capacity to act on screening findings. Facilities maintaining these programs depend on reliable lab supplies and respiratory protection to support the full screening and response pathway.
